Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis

First MMRV vaccine dose in children aged 10-24 months was associated with an elevated risk of seizure or febrile seizure. Further post-marketing restudies based on more rigorous study design are needed to confirm the findings.